CJC-1295 No DAC + Ipamorelin Blend 10mg
CA$105.00
CJC-1295 and Ipamorelin are used in laboratory research to investigate GHRH-associated signalling frameworks, ghrelin receptor pathway interaction, and growth hormone regulatory architecture in studies.
CJC-1295 (no DAC) and Ipamorelin blend is a research peptide combination that brings together two mechanistically distinct growth hormone secretagogues designed to act synergistically along the growth hormone axis. CJC-1295 (Mod GRF 1–29) engages GHRH receptors to promote cAMP/PKA-mediated growth hormone synthesis, while Ipamorelin selectively binds the ghrelin receptor (GHS-R1a), triggering Gq/11-dependent intracellular calcium signalling. When paired, this combination serves as a valuable model for investigating peptide-driven growth hormone pulse, receptor cross-talk, and hypothalamic–pituitary regulation within controlled experimental environments.
Composition: 10 mg lyophilized blend per vial
5 mg CJC-1295 no(DAC) | 5 mg Ipamorelin
RELATED PRODUCTS
